Collaborative Stage for TNM 7 - Revised 11/22/2010

LymphomaOcularAdnexa

Lymphoma of the Ocular Adnexa and Skin of Eyelid

C44.1, C69.0, C69.5-C69.6

CS Tumor Size
CS Extension
CS Tumor Size/Ext Eval
CS Lymph Nodes
CS Lymph Nodes Eval
Regional Nodes Positive
Regional Nodes Examined
CS Mets at DX
CS Mets Eval
CS Site-Specific Factor 1
Associated with HIV/AIDS
CS Site-Specific Factor 2
Systemic Symptoms at Diagnosis
CS Site-Specific Factor 3
International Prognostic Index (IPI)
CS Site-Specific Factor 4
Follicular Lymphoma Prognostic Index (FLIPI)
CS Site-Specific Factor 5
Ki-67/MIB-1 Labeling Index (LI): Ophthalmic
CS Site-Specific Factor 6
Lactate Dehydrogenase (LDH)
CS Site-Specific Factor 7
Rheumatoid Arthritis
CS Site-Specific Factor 8
Sjogren Syndrome
CS Site-Specific Factor 9
Other Connective Tissue Disease
CS Site-Specific Factor 10
Sicca Syndrome
CS Site-Specific Factor 11
Other Viral Infection
CS Site-Specific Factor 12
Bacterial Infection
CS Site-Specific Factor 13
Other infection
CS Site-Specific Factor 14 = 988
CS Site-Specific Factor 15 = 988
CS Site-Specific Factor 16 = 988
CS Site-Specific Factor 17 = 988
CS Site-Specific Factor 18 = 988
CS Site-Specific Factor 19 = 988
CS Site-Specific Factor 20 = 988
CS Site-Specific Factor 21 = 988
CS Site-Specific Factor 22 = 988
CS Site-Specific Factor 23 = 988
CS Site-Specific Factor 24 = 988
CS Site-Specific Factor 25 = 988
Histology Inclusion Table AJCC 7th ed.
Histology Exclusion Table AJCC 6th ed. = NA
AJCC TNM 7 Stage for sites with no stage groupings
AJCC TNM 6 Stage
Summary Stage
AJCC TNM 6 Stage CSv1
Revision Info   List of Schemas